AQST Historical Earnings image   This AQST historical earnings page last updated 5/9/2024
AQST Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20245/7/20240.01B
Q4 20233/5/20240.01B
Q3 202311/6/20230.01B
Q2 20238/7/20230.01B
Q1 20235/2/20230.01B
Q4 20223/7/20230.01B
Q3 202211/1/20220.01B
Q2 20228/2/20220.01B
Q1 20225/3/20220.01B
Q4 20213/8/20220.01B
Q3 202111/2/20210.01B
Q2 20218/3/20210.02B
Q1 20215/4/20210.01B
Q4 20203/9/20210.01B
Q3 202011/4/20200.01B
Q2 20208/4/20200.02B
Q1 20205/5/20200.01B
Q4 20193/11/20200.02B
Q3 201911/5/20190.01B
Q2 20198/6/20190.01B
Q1 20195/8/20190.01B
Q4 20183/14/201916.82M
AQST Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q1 20245/7/2024-0.170
Q4 20233/5/2024-0.100
Q3 202311/6/2023-0.030
Q2 20238/7/2023-0.100
Q1 20235/2/20230.110
Q4 20223/7/2023-0.230
Q3 202211/1/2022-0.230
Q2 20228/2/2022-0.360
Q1 20225/3/2022-0.320
Q4 20213/8/2022-0.380
Q3 202111/2/2021-0.370
Q2 20218/3/2021-0.330
Q1 20215/4/2021-0.410
Q4 20203/9/2021-0.600
Q3 202011/4/2020-0.490
Q2 20208/4/2020-0.070
Q1 20205/5/2020-0.490
Q4 20193/11/2020-0.480
Q3 201911/5/2019-0.540
Q2 20198/6/2019-0.820
Q1 20195/8/2019-0.590
Q4 20183/14/2019-0.56
Quotes delayed 20 minutes

Email EnvelopeFree AQST Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aquestive Therapeutics (AQST) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ARAV Historical Earnings
ARAY Historical Earnings
ARCT Historical Earnings
ARDS Historical Earnings
ARDX Historical Earnings
ARNA Historical Earnings
ARPO Historical Earnings
ARQT Historical Earnings
ARTL Historical Earnings
ARVN Historical Earnings
What was the record high AQST historical earnings result?
In terms of earnings or revenue, what is the best AQST historical earnings result that Aquestive Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest AQST historical earnings result was set in Q1 2023, when Aquestive Therapeutics posted results of 0.110/share. The most successful revenue quarter within our data set was Q2 2020 when Aquestive Therapeutics reported revenue of 0.02B.

What was the lowest Aquestive Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest AQST has reported, and when?

✔️Accepted answer: Within our data set, the lowest AQST historical earnings result was set in Q2 2019, when Aquestive Therapeutics posted results of -0.820/share. The smallest revenue quarter within our data set was Q4 2020 when Aquestive Therapeutics reported revenue of 0.01B.

On this page we presented the AQST historical earnings date information for Aquestive Therapeutics. Reviewing that AQST Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2023, when AQST posted gaap of 0.110/share. Meanwhile the lowest AQST historical earnings result was in Q2 2019, when AQST posted gaap of -0.820/share. Moving to Aquestive Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2020 when AQST reported 0.02B in revenue, while the smallest revenue quarter was Q4 2020 when AQST reported 0.01B in revenue.

For self directed investors doing their due diligence on AQST or any other given stock, their research can benefit from looking into all of the Aquestive Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you to make it more convenient for investors to look into Aquestive Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for AQST. Thanks for visiting, and the next time you need to research AQST historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: MHE market cap history, EMPR Insider Buying, FMC Historical Earnings.


AQST Historical Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.